| scholarly article | Q13442814 |
| P50 | author | Marek Jutel | Q11768191 |
| Alexandra F. Santos | Q51051772 | ||
| Victoria Cardona | Q54153242 | ||
| Philippe Eigenmann | Q54153243 | ||
| Abdelouahab Bellou | Q56855468 | ||
| Susanne Halken | Q67251927 | ||
| Pascal Demoly | Q72651113 | ||
| Carsten Bindslev-Jensen | Q45909111 | ||
| Aziz Sheikh | Q42725577 | ||
| P2093 | author name string | G Roberts | |
| A T Clark | |||
| B Niggemann | |||
| A Muraro | |||
| C A Akdis | |||
| K Beyer | |||
| M Worm | |||
| F Ruëff | |||
| M B Bilò | |||
| T Werfel | |||
| A DunnGalvin | |||
| G Lack | |||
| K Brockow | |||
| A E J Dubois | |||
| B J Vlieg-Boerstra | |||
| EAACI Food Allergy and Anaphylaxis Guidelines Group | |||
| S Panesar | |||
| L Harada | |||
| F Timmermans | |||
| S Dhami | |||
| Z Q Zolkipli | |||
| M Fernández Rivas | |||
| P2860 | cites work | Allergy and the cardiovascular system | Q24644929 |
| A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy | Q26824130 | ||
| Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project | Q28207852 | ||
| Implementation of anaphylaxis management guidelines: a register-based study | Q28730033 | ||
| Effects of educational interventions for self management of asthma in children and adolescents: systematic review and meta-analysis | Q30478140 | ||
| The strategies that peanut and nut-allergic consumers employ to remain safe when travelling abroad | Q30526486 | ||
| Fatalities due to anaphylactic reactions to foods | Q31812490 | ||
| Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations | Q51006907 | ||
| How do teenagers manage their food allergies? | Q51757150 | ||
| Regimens of Hymenoptera venom immunotherapy. | Q52534632 | ||
| First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). | Q52580532 | ||
| Side-effects of insect venom immunotherapy: results from an EAACI multicenter study. European Academy of Allergology and Clinical Immunology. | Q52584319 | ||
| Analysis of the burden of treatment in patients receiving an EpiPen for yellow jacket anaphylaxis. | Q52672020 | ||
| Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensiti | Q52699890 | ||
| Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience. | Q52731268 | ||
| Oral peanut immunotherapy in children with peanut anaphylaxis. | Q52903267 | ||
| Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. | Q54153238 | ||
| Symposium on the definition and management of anaphylaxis: summary report. | Q55040480 | ||
| Further fatalities caused by anaphylactic reactions to food, 2001-2006. | Q55043255 | ||
| Further fatal allergic reactions to food in the United Kingdom, 1999-2006. | Q55043542 | ||
| European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: Electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, p | Q55868024 | ||
| The use of adrenaline autoinjectors by children and teenagers | Q57173865 | ||
| Risk factors for severe pediatric food anaphylaxis in Italy | Q57213767 | ||
| Anaphylaxis in the community: learning from the survivors. | Q45961637 | ||
| Clinical predictors for biphasic reactions in children presenting with anaphylaxis. | Q45987927 | ||
| Immunotherapy for hymenoptera venom allergy: too expensive for European health care? | Q46147776 | ||
| Practices in the prescription of adrenaline autoinjectors | Q46173602 | ||
| Should children with a history of anaphylaxis to foods undergo challenge testing? | Q46389740 | ||
| Use of multiple doses of epinephrine in food-induced anaphylaxis in children | Q46545169 | ||
| Allergic reactions in the community: a questionnaire survey of members of the anaphylaxis campaign | Q46559689 | ||
| Efficacy of a management plan based on severity assessment in longitudinal and case-controlled studies of 747 children with nut allergy: proposal for good practice | Q46559692 | ||
| Emergency treatment of anaphylactic reactions--guidelines for healthcare providers | Q46688864 | ||
| Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10. | Q46703797 | ||
| Anaphylactic reactions in children--a questionnaire-based survey in Germany | Q46730009 | ||
| Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice | Q46787767 | ||
| The psychosocial impact of anaphylaxis on young people and their parents. | Q50893710 | ||
| Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan | Q31988734 | ||
| Factors associated with shock in anaphylaxis | Q33161104 | ||
| Algorithm for the diagnosis of anaphylaxis and its validation using population-based data on emergency department visits for anaphylaxis in Florida | Q33602265 | ||
| Use assessment of self-administered epinephrine among food-allergic children and pediatricians | Q33828223 | ||
| Provoking allergens and treatment of anaphylaxis in children and adolescents--data from the anaphylaxis registry of German-speaking countries | Q33854735 | ||
| Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial | Q33900318 | ||
| Lessons for management of anaphylaxis from a study of fatal reactions | Q33994451 | ||
| Anaphylaxis during anesthesia in France: an 8-year national survey | Q34026551 | ||
| Stinging insect hypersensitivity: a practice parameter update 2011. | Q34175153 | ||
| Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment | Q34192110 | ||
| Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. | Q34319335 | ||
| World allergy organization guidelines for the assessment and management of anaphylaxis | Q34319703 | ||
| Clinical features and severity grading of anaphylaxis | Q34341881 | ||
| H2-antihistamines for the treatment of anaphylaxis with and without shock: a systematic review | Q34400351 | ||
| AGREE II: advancing guideline development, reporting and evaluation in health care | Q34403979 | ||
| Biphasic anaphylactic reactions | Q34456245 | ||
| Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial | Q34557064 | ||
| Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers | Q35346877 | ||
| Multicenter study of emergency department visits for food allergies | Q35651430 | ||
| Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization | Q35685149 | ||
| What factors affect the carriage of epinephrine auto-injectors by teenagers? | Q35822454 | ||
| Development and validation of educational materials for food allergy | Q35840142 | ||
| Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community | Q36064759 | ||
| Paediatric emergency department anaphylaxis: different patterns from adults. | Q36152733 | ||
| The difficulties of diagnosing food-dependent exercise-induced anaphylaxis in childhood -- a case study and review | Q36450755 | ||
| Multicenter study of repeat epinephrine treatments for food-related anaphylaxis | Q36492714 | ||
| Research needs in allergy: an EAACI position paper, in collaboration with EFA. | Q36517533 | ||
| Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review | Q36552782 | ||
| Living with severe allergy: an Anaphylaxis Campaign national survey of young people | Q36575537 | ||
| The skin prick test - European standards | Q36591592 | ||
| Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients. | Q36709165 | ||
| The acute and long-term management of anaphylaxis: protocol for a systematic review | Q36766918 | ||
| Action plans for the long-term management of anaphylaxis: systematic review of effectiveness. | Q36854128 | ||
| The epidemiology of anaphylaxis in Europe: protocol for a systematic review | Q36937570 | ||
| Factors associated with repeated use of epinephrine for the treatment of anaphylaxis | Q37044596 | ||
| The role of written action plans in childhood asthma | Q37100916 | ||
| Anaphylaxis management plans for the acute and long-term management of anaphylaxis: a systematic review. | Q37197763 | ||
| Paediatric anaphylaxis: a 5 year retrospective review. | Q37240083 | ||
| Gaps in anaphylaxis management at the level of physicians, patients, and the community: a systematic review of the literature | Q37661118 | ||
| Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review | Q37731041 | ||
| Efficacy of therapeutic patient education in chronic diseases and obesity | Q37736061 | ||
| Specific immunotherapy using Hymenoptera venom: systematic review | Q37761635 | ||
| Anaphylaxis to radiographic contrast media | Q37887440 | ||
| Effect of pre-medication on early adverse reactions following antivenom use in snakebite: a systematic review and meta-analysis | Q37924277 | ||
| Managing anxiety related to anaphylaxis in childhood: a systematic review | Q37946899 | ||
| Anaphylaxis and reactions to foods in children--a population-based case study of emergency department visits | Q37993619 | ||
| 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis | Q38022499 | ||
| Anaphylaxis in the community setting: determining risk factors for admission. | Q38030080 | ||
| Anaphylaxis during pregnancy | Q38032645 | ||
| Anaphylaxis: the acute episode and beyond | Q38081049 | ||
| The epidemiology of anaphylaxis in Europe: a systematic review. | Q38151836 | ||
| Management of anaphylaxis: a systematic review | Q38164031 | ||
| Histamine antagonists in the treatment of acute allergic reactions | Q39503427 | ||
| Symptom profile and risk factors of anaphylaxis in Central Europe | Q39652242 | ||
| Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines | Q39716681 | ||
| Teenagers' experiences of living with food hypersensitivity: a qualitative study | Q39952899 | ||
| Anaphylaxis in an emergency setting - elicitors, therapy and incidence of severe allergic reactions | Q41973648 | ||
| Severe anaphylactic reactions outside hospital: etiology, symptoms and treatment | Q42080314 | ||
| Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients | Q42523478 | ||
| Effectiveness of specific immunotherapy in the treatment of hymenoptera venom hypersensitivity: a meta-analysis | Q42632602 | ||
| Good prognosis, clinical features, and circumstances of peanut and tree nut reactions in children treated by a specialist allergy center | Q43527479 | ||
| Developmental pathways in food allergy: a new theoretical framework | Q43675459 | ||
| Biphasic systemic anaphylaxis: an inpatient and outpatient study | Q43772888 | ||
| Epinephrine absorption in adults: intramuscular versus subcutaneous injection | Q43787644 | ||
| EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis | Q43859482 | ||
| The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. | Q43864152 | ||
| Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom | Q44058588 | ||
| Evaluation of national institute of allergy and infectious diseases/food allergy and anaphylaxis network criteria for the diagnosis of anaphylaxis in emergency department patients. | Q44448615 | ||
| Influence of a multidisciplinary paediatric allergy clinic on parental knowledge and rate of subsequent allergic reactions | Q44756454 | ||
| Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. | Q44925500 | ||
| Frequency of food-dependent, exercise-induced anaphylaxis in Japanese junior-high-school students | Q45023190 | ||
| Risk factors for childhood asthma deaths from the UK Eastern Region Confidential Enquiry 2001-2006. | Q45900567 | ||
| P433 | issue | 8 | |
| P921 | main subject | immunology | Q101929 |
| anaphylaxis | Q168800 | ||
| anaphylactic shock | Q15965523 | ||
| P304 | page(s) | 1026-1045 | |
| P577 | publication date | 2014-06-09 | |
| P1433 | published in | Allergy | Q2699825 |
| P1476 | title | Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology | |
| P478 | volume | 69 |
| Q60053969 | "Two Stones on One Bird": A Case Report on Severe Biphasic Anaphylaxis Masquerading as Life-Threatening Acute Asthma |
| Q34500152 | 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines |
| Q93152023 | A Case of a Child With Several Anaphylactic Reactions to Drugs |
| Q38669229 | A national survey of Russian physicians' knowledge of diagnosis and management of food-induced anaphylaxis. |
| Q89790715 | A rash decision. The hazards of the wrongful use of adrenaline |
| Q33765016 | Acute kidney injury complicating bee stings - a review. |
| Q39317544 | Adrenaline in anaphylaxis treatment and self-administration: experience from an inner city emergency department |
| Q53641907 | Adrenaline in anaphylaxis: overtreatment in theory, undertreatment in reality. |
| Q58798414 | Adrenaline in the Acute Treatment of Anaphylaxis |
| Q40812370 | Adverse events of monoclonal antibodies used for cancer therapy |
| Q47649380 | Alexithymia in food-allergic versus healthy children and young adults |
| Q37623049 | Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms |
| Q58758914 | Anaphylactic Shock During Pediatric Anesthesia: An Unexpected Reaction to Sevoflurane |
| Q37146819 | Anaphylactic reactions presenting with hypertension |
| Q37306621 | Anaphylactic shock caused by intramuscular injection of midazolam during the perioperative period: a case report |
| Q88757895 | Anaphylaxis |
| Q54580302 | Anaphylaxis Knowledge Among Pediatric Intensivists in Brazil: A Multicenter Survey. |
| Q38364807 | Anaphylaxis and cardiovascular disease: therapeutic dilemmas |
| Q64093177 | Anaphylaxis in Elderly Patients-Data From the European Anaphylaxis Registry |
| Q37593818 | Anaphylaxis in a 4-year-old male caused by contact with grasses: a case report |
| Q47142778 | Anaphylaxis in an emergency care setting: a one year prospective study in children and adults. |
| Q55374006 | Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers. |
| Q37514618 | Anaphylaxis in the community: a questionnaire survey of members of the UK Anaphylaxis Campaign |
| Q58735242 | Anaphylaxis management: a survey of school and day care nurses in Lebanon |
| Q57161524 | Anaphylaxis triggers in a large tertiary care hospital in Qatar: a retrospective study |
| Q92960027 | Antibiotic Hypersensitivity Mechanisms |
| Q64277257 | Antibiotic prophylaxis for the prevention of infective endocarditis for dental procedures is not associated with fatal adverse drug reactions in France |
| Q92782312 | Asthma and Food Allergy: Which Risks? |
| Q39325571 | Asthma, Food Allergy, and How They Relate to Each Other |
| Q48292169 | B-FAHF-2 plus oral immunotherapy (OIT) is safer and more effective than OIT alone in a murine model of concurrent peanut/tree nut allergy. |
| Q38610629 | BSACI guideline for the diagnosis and management of peanut and tree nut allergy. |
| Q47376781 | Basal serum tryptase is not a risk factor for immediate-type drug hypersensitivity during childhood |
| Q90265942 | Bee Updated: Current Knowledge on Bee Venom and Bee Envenoming Therapy |
| Q91141535 | Beta-lactam allergy in Chinese patients and factors predicting genuine allergy |
| Q30251449 | Can we identify patients at risk of life-threatening allergic reactions to food? |
| Q38944010 | Cashew Nut Allergy: Clinical Relevance and Allergen Characterisation. |
| Q47149942 | Chinese Guideline on allergen immunotherapy for allergic rhinitis |
| Q30384820 | Clinical Characteristics of Inpatients with Anaphylaxis in China |
| Q26798184 | Clinical development methodology for infusion-related reactions with monoclonal antibodies |
| Q47425341 | Clinical features and treatment of pediatric patients with drug-induced anaphylaxis: a study based on pharmacovigilance data |
| Q37467614 | Cofactors in allergic reactions to food: physical exercise and alcohol are the most important |
| Q61809391 | Common causes of emergency department visits for anaphylaxis in Korean community hospitals: A cross-sectional study |
| Q48277134 | Conjunctival provocation test in diagnosis of peanut allergy in children. |
| Q52597625 | Critical view of anaphylaxis epidemiology: open questions and new perspectives. |
| Q41372972 | Design and validation of pictograms in a pediatric anaphylaxis action plan |
| Q49722271 | Development and validation of an algorithm to identify drug-induced anaphylaxis in the Beijing Pharmacovigilance Database. |
| Q90219563 | Development of a model care pathway for the management of Hymenoptera venom allergy: evidence-based key interventions and indicators |
| Q37712371 | Development of an allergy management support system in primary care |
| Q28073240 | Diagnosis of exercise-induced anaphylaxis: current insights |
| Q89885575 | Differences in omega-5-gliadin allergy: East versus West |
| Q38603594 | Differences in the Anaphylactic Response between C3H/HeOuJ and BALB/c Mice |
| Q34808067 | Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut |
| Q48503061 | Downstream consequences of diagnostic error in pediatric anaphylaxis |
| Q47727860 | Drug-induced anaphylaxis in China: a 10 year retrospective analysis of the Beijing Pharmacovigilance Database. |
| Q89206215 | Drug-induced anaphylaxis in the emergency room |
| Q57919564 | EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy |
| Q95273779 | EAACI Task force Clinical epidemiology of anaphylaxis: experts' perspective on the use of adrenaline autoinjectors in Europe |
| Q58694686 | Emergency anaphylaxis protocols: A cross-sectional analysis of general practice surgeries and pharmacies in both the urban and rural setting in Ireland |
| Q52631095 | Epidemiology and outcomes of anaphylaxis-associated out-of-hospital cardiac arrest. |
| Q33734529 | Epidemiology, Mechanisms, and Diagnosis of Drug-Induced Anaphylaxis |
| Q96304043 | Epinephrine delivery via EpiPen® Auto-Injector or manual syringe across participants with a wide range of skin-to-muscle distances |
| Q38347027 | Evaluation and management of hypersensitivity reactions to chemotherapy agents. |
| Q100466039 | Evaluation of oral immunotherapy efficacy and safety by maintenance dose dependency: A multicenter randomized study |
| Q42177436 | Excess subcutaneous tissue may preclude intramuscular delivery when using adrenaline autoinjectors in patients with anaphylaxis. |
| Q58113519 | Exercise-Induced Anaphylaxis: Literature Review and Recent Updates |
| Q64060346 | Exercise-induced anaphylaxis with an Ayurvedic drug as cofactor: A case report |
| Q41585218 | Factors associated with good adherence to self-care behaviours amongst adolescents with food allergy |
| Q38259253 | Factors augmenting allergic reactions |
| Q31154653 | Fatal anaphylaxis registries data support changes in the who anaphylaxis mortality coding rules |
| Q59153904 | Food allergy |
| Q39436463 | Food allergy phenotypes: The key to personalized therapy |
| Q28384312 | Food dependant exercise induced anaphylaxis a retrospective study from 2 allergy clinics in Colombo, Sri Lanka |
| Q89110476 | Food-Induced Anaphylaxis: an Update |
| Q31105062 | Food-induced anaphylaxis - data from the anaphylaxis registry |
| Q90717463 | Gaps between actual initial treatment of anaphylaxis in China and international guidelines: A review and analysis of 819 reported cases |
| Q38438009 | Global perceptions of food allergy thresholds in 16 countries |
| Q47623138 | Green, Yellow, and Red risk perception in everyday life - a communication tool. |
| Q35777131 | Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergolo |
| Q37316684 | Heated egg yolk challenge predicts the natural course of hen's egg allergy: a retrospective study |
| Q50056731 | How does dose impact on the severity of food-induced allergic reactions, and can this improve risk assessment for allergenic foods?: Report from an ILSI Europe Food Allergy Task Force Expert Group and Workshop |
| Q47103026 | How to manage anaphylaxis in primary care. |
| Q33166619 | Hymenoptera Allergy and Mast Cell Activation Syndromes |
| Q38543373 | Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association |
| Q55293221 | Hymenoptera sting reactions in southern Italy forestry workers: our experience compared to reported data. |
| Q37669432 | Hymenoptera venom allergy in outdoor workers: Occupational exposure, clinical features and effects of allergen immunotherapy |
| Q64232202 | Hypersensitivity Reactions in Serious Adverse Events Reported for Paracetamol in the EudraVigilance Database, 2007⁻2018 |
| Q38534386 | Identification and practical management of latex allergy in occupational settings |
| Q52873759 | Idiopathic Anaphylaxis. |
| Q39276655 | IgE-mediated food allergies in children: prevalence, triggers, and management |
| Q91760679 | Improving adrenaline autoinjector adherence: A psychologically informed training for healthcare professionals |
| Q51530337 | Improving quality in allergy care. |
| Q89287410 | In situ simulation in the management of anaphylaxis in a pediatric emergency department |
| Q39410676 | Inaccurate diagnosis of paediatric anaphylaxis in three Australian Emergency Departments. |
| Q47276413 | Individual healthcare plan for allergic children at school: Lessons from a 2015-2016 school year survey |
| Q64080706 | Ingestion of mammalian meat and alpha-gal allergy: Clinical relevance in primary care |
| Q27468685 | International Consensus (ICON): allergic reactions to vaccines |
| Q33687257 | International consensus on (ICON) anaphylaxis |
| Q39128920 | Investigating the accuracy, risk impact, and cost-effectiveness of component-resolved diagnostic test for food allergy: a systematic review protocol |
| Q58037992 | Kurzdarstellung |
| Q90453490 | Long-term effects and significant Adverse Drug Reactions (ADRs) associated with the use of Gonadotropin-Releasing Hormone analogs (GnRHa) for central precocious puberty: a brief review of literature |
| Q37710655 | Low percentage of clinically relevant pistachio nut and mango co-sensitisation in cashew nut sensitised children. |
| Q26766190 | Management and Prevention of Anaphylaxis |
| Q50205188 | Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines. |
| Q38861295 | Markers of tolerance development to food allergens. |
| Q100466047 | Medical devices in allergy practice |
| Q35953742 | Multicentre Double-Blind Placebo-Controlled Food Challenge Study in Children Sensitised to Cashew Nut |
| Q33690086 | Multifactorial Modulation of Food-Induced Anaphylaxis |
| Q89126699 | Myths, facts and controversies in the diagnosis and management of anaphylaxis |
| Q38369257 | National clinical practice guidelines for food allergy and anaphylaxis: an international assessment |
| Q92540231 | New antihistamines - perspectives in the treatment of some allergic and inflammatory disorders |
| Q47681622 | No difference in health-related quality of life, after a food challenge with cashew nut in children participating in a clinical trial. |
| Q38265001 | Occupational anaphylaxis--an EAACI task force consensus statement |
| Q34604574 | Omalizumab in children |
| Q38534844 | Pathophysiological mechanisms of exercise-induced anaphylaxis: an EAACI position statement. |
| Q36302454 | Patients' ability to treat anaphylaxis using adrenaline autoinjectors: a randomized controlled trial |
| Q38764567 | Patterns of anaphylaxis after diagnostic workup: A follow-up study of 226 patients with suspected anaphylaxis |
| Q92375360 | Pegvaliase: Immunological profile and recommendations for the clinical management of hypersensitivity reactions in patients with phenylketonuria treated with this enzyme substitution therapy |
| Q64255799 | Personalized Nutrition Approach in Food Allergy: Is It Prime Time Yet? |
| Q47780017 | Pistachio nut allergy: An updated overview |
| Q38533438 | Position paper of the EAACI: food allergy due to immunological cross-reactions with common inhalant allergens |
| Q37587081 | Pre-hospital treatment of bee and wasp induced anaphylactic reactions: a retrospective study. |
| Q38910501 | Prescription rates of adrenaline auto-injectors for children in UK general practice: a retrospective cohort study |
| Q57784320 | Prevalence of anaphylaxis and prescription rates of epinephrine auto-injectors in urban and rural areas of Korea |
| Q58513257 | Prise en charge de l’anaphylaxie en médecine d’urgence. Recommandations de la Société française de médecine d’urgence (SFMU) en partenariat avec la Société française d’allergologie (SFA) et le Groupe francophone de réanimation et d? |
| Q53354591 | Provocation tests for the diagnosis of food-dependent exercise-induced anaphylaxis. |
| Q92809142 | Proximity-Based Emergency Response Communities for Patients With Allergies Who Are at Risk of Anaphylaxis: Clustering Analysis and Scenario-Based Survey Study |
| Q40311195 | Pru p 3, a marker allergen for lipid transfer protein sensitization also in Central Europe. |
| Q33721881 | Quality indicators for the acute and long-term management of anaphylaxis: a systematic review |
| Q39099662 | Quality of life in childhood, adolescence and adult food allergy: Patient and parent perspectives. |
| Q26764797 | Quality of life in patients with food allergy |
| Q90450409 | Reduced iodinated contrast media dose and injection speed for CT: how much does this decrease the risk of a hypersensitivity reactions? |
| Q30371972 | Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement |
| Q34504409 | Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study |
| Q59460188 | Schleimhauterkrankungen aus allergologischer Sicht |
| Q47205101 | School Nurses on the Front Lines of Medicine: Take a BREATH: The Approach to a Student With Respiratory Distress |
| Q51533907 | Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI Task Force Consensus Statement. |
| Q36536239 | Should adrenaline be used in patients with hemodynamically stable anaphylaxis? Incident case control study nested within a retrospective cohort study |
| Q26801123 | Stinging insect allergy: current perspectives on venom immunotherapy |
| Q37231367 | The Basophil Activation Test Is Safe and Useful for Confirming Drug-Induced Anaphylaxis |
| Q40552110 | The Epidemiology of Anaphylaxis |
| Q93051178 | The Incidence and Risk Factors for Adverse Drug Reactions Related to Tanreqing Injection: A Large Population-Based Study in China |
| Q90205510 | The Occurrence of Food Hypersensitivity Reactions and the Relation to the Sensitization to Grass and Trees in Atopic Dermatitis Patients 14 Years of Age and Older |
| Q47761576 | The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease |
| Q38259275 | The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases. |
| Q40383885 | The diagnosis and management of children presenting with anaphylaxis to a metropolitan emergency department: A 2-year retrospective case series |
| Q47810222 | The pathophysiology of anaphylaxis |
| Q90549739 | Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database |
| Q38809512 | Treatment of allergic children - Where is the progress (for the practicing allergist)? |
| Q50608801 | Triggers, risk factors and clinico-pathological features of urticaria in dogs - a prospective observational study of 24 cases. |
| Q30400473 | Update on the usage and safety of epinephrine auto-injectors, 2017. |
| Q33749743 | Use of Epinephrine in Patients with Drug-Induced Anaphylaxis: An Analysis of the Beijing Pharmacovigilance Database |
| Q40105652 | Vaccination and allergy: EAACI position paper, practical aspects. |
| Q102142849 | World allergy organization anaphylaxis guidance 2020 |
| Q52562417 | [Allergic emergencies]. |
| Q52816155 | [Anaphylaxis - Causes, therapy and prevention]. |
| Q52852069 | [Food allergy in childhood]. |
| Q53654027 | [Interest of allergy tests in urticaria]. |
| Q85472626 | [Prevention of allergies in utero and in the neonatal period] |
| Q85235925 | [Shock in infants and children] |
| Q85472499 | [What symptoms indicate a food allergy?] |
| Q51577834 | sIgE Ana o 1, 2 and 3 accurately distinguish tolerant from allergic children sensitized to cashew nuts. |
Search more.